Pharmacokinetic studies with recombinant hirudin in dogs.

Abstract

The knowledge of the pharmacokinetics of recombinant hirudin is essential for potential clinical use of this selective thrombin inhibitor. For detailed information about absorption, distribution and elimination, pharmacokinetic studies with recombinant hirudin were carried out in dogs. The plasma concentration time curve after intravenous injection could be… (More)

Topics

  • Presentations referencing similar topics